Clinical Outcomes and Safety of Apatinib Mesylate in the Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Patients Who Progressed After Standard Therapy and Analysis of the KDR Gene Polymorphism
Zi-Zheng Song, 1 Li-Fen Zhao, 2 Jing Zuo, 3 Zhi-Song Fan, 3 Long Wang, 3 Yu-Dong Wang 3 1Department of Medical Oncology, The Affiliated Hospital of Hebei University, Baoding, People’s Republic of China; 2Department of Respiratory and Critical Care Medicine, The Shanxi Dayi Hospital, Taiy...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-01-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-outcomes-and-safety-of-apatinib-mesylate-in-the-treatment-of--peer-reviewed-article-OTT |